Patriot Financial Group Insurance Agency’s Sarepta Therapeutics SRPT Stock Holding History

Patriot Financial Group Insurance Agency’s Portfolio SRPT Stock Details SRPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-70	Closed	-$5K	–	1757
2022 Q2	$5K	Sell	70 -500	-88%	-$36.8K	﹤0.01%	1506
2022 Q1	$45K	Hold	570	–	–	0.01%	813
2021 Q4	$51K	Sell	570 -500	-47%	-$42.7K	0.01%	855
2021 Q3	$99K	Hold	1,070	–	–	0.02%	658
2021 Q2	$83K	Hold	1,070	–	–	0.02%	688
2021 Q1	$80K	Buy	1,070 +494	+86%	+$45.6K	0.02%	627
2020 Q4	$98K	Buy	576 +140	+32%	+$20.7K	0.02%	503
2020 Q3	$61K	Buy	436 +200	+85%	+$30.4K	0.02%	495
2020 Q2	$38K	Buy	236 +25	+12%	+$3.4K	0.01%	579
2020 Q1	$21K	Buy	211 +105	+99%	+$12K	0.01%	654
2019 Q4	$14K	Hold	106	–	–	0.01%	770
2019 Q3	$8K	Hold	106	–	–	﹤0.01%	852
2019 Q2	$16K	Buy	106 +100	+1,667%	+$12.2K	0.01%	709
2019 Q1	$1K	Buy	+6	New	+$771	﹤0.01%	1170

Other funds holding SRPT

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Patriot Financial Group Insurance Agency's SRPT Position: Q3 2022 in Review

Patriot Financial Group Insurance Agency sold out of Sarepta Therapeutics (SRPT) in Q3 2022, closing a stake of 70 shares — an estimated $5K sold.

Patriot Financial Group Insurance Agency first reported a position in SRPT in Q1 2019 and held it in 14 quarters. The position peaked at $99K in Q3 2021. 376 funds tracked by Wall St. Rank hold SRPT as of Q3 2022.

Patriot Financial Group Insurance Agency reported no remaining Sarepta Therapeutics position as of Q3 2022 after selling out during the quarter.
Patriot Financial Group Insurance Agency sold 70 Sarepta Therapeutics shares in Q3 2022, an estimated $5K.
Patriot Financial Group Insurance Agency first reported a position in Sarepta Therapeutics in Q1 2019 and held it in 14 quarters.
Patriot Financial Group Insurance Agency's Sarepta Therapeutics position peaked at $99K in Q3 2021.
376 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q3 2022.

Based on Patriot Financial Group Insurance Agency's 13F filing for Q3 2022, filed 1 Nov 2022.